Biparatopic single-domain antibodies against Axl achieve ultra-high affinity through intramolecular engagement

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1016/j.bbrc.2021.05.030
AuthorSearch for: 1ORCID identifier: https://orcid.org/0000-0003-0477-0558; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1
Affiliation
  1. National Research Council of Canada. Human Health Therapeutics
FunderSearch for: National Research Council of Canada
FormatText, Article
Subjectsingle-domain antibody; nanobody; VHH; cancer; Axl; receptor tyrosine kinase; TAM family
Abstract
Publication date
PublisherElsevier
In
LanguageEnglish
Peer reviewedYes
IdentifierS0006291X21008019
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifier6875c0a7-0ed5-4122-9ea2-81b34a675d11
Record created2022-09-23
Record modified2023-03-16
Date modified: